No Data
Hong Kong stock announcement for investment | alibaba-W reported a net income of 43.547 billion yuan in the second quarter, an increase of 63% year-on-year, while Gaode's daily active users peaked at over 0.3 billion, setting a new historical high.
Alibaba-W (09988) released its interim results, with net income attributable to ordinary shareholders of 68.143 billion yuan, an increase of 9.84% year-on-year; Lenovo Group (00992) achieved multiple new records in its first-half performance, with profit attributable to equity holders of 0.602 billion USD, a year-on-year growth of 41%.
Sinopharm vaccine (06660.HK) serum-free iteration of rabies vaccine has been submitted for pre-registration for listing.
AstraZeneca (06660.HK) announced that the group's independently developed serum-free iterative rabies vaccine has submitted a pre-application for market registration to the National Medical Products Administration. According to the results of the Phase III clinical trial with completed unblinding, the serum-free iterative rabies vaccine has demonstrated good safety, immunogenicity, and immune persistence, achieving the clinical preset goals.
The registration for the 13-valent combined pneumococcal vaccine has been officially accepted, and it has obtained a pharmaceutical production license.
One AIM Vaccine Insider Raised Stake By 27% In Previous Year
Hong Kong stock market anomaly | AstraZeneca vaccine (06660) rose more than 7% during the day, iterating the double-stranded rabies vaccine for clinical application. Recent progress in the declaration of multiple products will be announced soon.
Amex vaccine (06660) rose more than 7% intraday, as of the deadline, up 5.01%, at HK$8.18, with a turnover of HK$57.4294 million.
AIM Vaccine Submits Application for Clinical Trial of Rabies Vaccine to Chinese Regulator
No Data
No Data